Cargando…
H3K9 acetylation modification and TLR9 immune regulation mechanism in patients after anti-HBV treatment
To improve the curative effect of anti-hepatitis B virus (HBV) drugs, methods such as thymosin and entecavir combination have become a focus of clinical investigation. The aim of this retrospective experimental study was to explore the potential mechanism of action of thymosin a1 (Ta1) combined with...
Autores principales: | Zhu, Haipeng, Wang, Ke, Du, Wei, Cao, Huanhuan, Zhong, Qingyang, Yin, Sichun, Zhong, Jianbo, Li, Fawu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803445/ https://www.ncbi.nlm.nih.gov/pubmed/36596032 http://dx.doi.org/10.1097/MD.0000000000032431 |
Ejemplares similares
-
Seroconverting nonresponder of high-dose intramuscular HBV vaccine with intradermal HBV vaccine: A case report
por: Das, Manjusha, et al.
Publicado: (2017) -
Upregulation of miRNA-130a Represents Good Prognosis in Patients With HBV-Related Acute-on-Chronic Liver Failure: A Prospective Study
por: Zheng, Qing-Fen, et al.
Publicado: (2016) -
Evaluation of the in situ assay for HBV DNA: An observational real-world study in chronic hepatitis B
por: Li, Chang, et al.
Publicado: (2021) -
Peripheral T lymphocytes predict the severity and prognosis in patients with HBV-related acute-on-chronic liver failure
por: Wang, Feixia, et al.
Publicado: (2021) -
Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosis
por: Zhu, ShaoMing, et al.
Publicado: (2017)